Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

A service tailored to people with workplace-based insurance coverage represents a new way for Lilly to bypass insurers and expand use of its popular obesity shot.

The Mexican president’s approval rating has recovered to 71% after slight declines since the summer. Both the downfall of the ...

An increasing number of women who use estrogen patches to help deal with perimenopause and menopause symptoms have been ...

Novo Nordisk A/S remains a Buy despite CagriSema setback; Eli Lilly and Company remains a Hold on valuation. Click for this ...

A training company that teaches medical providers how to perform cosmetic injections has partnered with the UNC School of Nursing in Chapel Hill to offer hands-on instruction in Botox and dermal ...

(TNND) — A popular potato chip flavor has been recalled by Frito-Lay after it was discovered that the product could contain ...

Regenxbio (RGNX) hit by FDA CRL for RGX-121; valuation discount, cash runway to 2027, risks vs RGX-202 upside. Click here to ...

The Trump administration has offered "vague mentions of imminent attacks by Iran and to prevent Iran from acquiring a nuclear weapon," while the UN Charter "requires, at the least, that evidence of a ...

Mosaic Clinical Technologies™, a wholly-owned subsidiary of Radiology Partners, is pleased to announce that Cognita™, its AI business unit developing ...

The United States’ justification for attacking Iran over alleged “direct threats” does not meet the threshold required under international law ...

Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that it has entered into a securities ...